* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Ebola Virus 2014 Kathryn Springer, MD
2015–16 Zika virus epidemic wikipedia , lookup
Herpes simplex research wikipedia , lookup
Transmission and infection of H5N1 wikipedia , lookup
Infection control wikipedia , lookup
Eradication of infectious diseases wikipedia , lookup
Canine distemper wikipedia , lookup
Canine parvovirus wikipedia , lookup
I have no disclosures. Index Cases Guinea December 2013 - March 2014 Index Case 1st victim, 2-year-old child in Guinea. Family hunted bat. Died 12/6/13. Women attending a funeral of a tradition healer who treated Guinean Ebola patients, spread it to Sierra Leone… Ebola virus disease (EVD) cumulative incidence* — West Africa, October 18, 2014 How Many Cases? As of Sep 22, 2014 As of 1/19/15, 21,649 people in Guinea, Liberia, Nigeria, Senegal, Sierra Leone, and Mali have contracted Ebola since March, 2014 Largest outbreak on record. More than 8609 people have died file:///C:/Users/cprice/Documents/What%20You%20Need%20to%20Kn ow%20About%20the%20Ebola%20Outbreak%20-%20NYTimes.com.html Expected # cases in Liberia and Sierra Leone Best-case scenario 4 0 2 Hundreds of Thousands 10 8 If the disease continues spreading without effective intervention 6 Assumes 70 percent of patients are treated in settings that confine the illness and that the dead are buried safely. About 18 percent of patients in Liberia and 40 percent in Sierra Leone are being treated in appropriate settings. 12 14 11,000-27,000 cases through Jan. 20 Worst-case Scenario 537,000-1.4 M cases through Jan. 20 http://www.nytimes.com/interactive/2014/07/31/world/africa/ebola-virus-outbreak-qa.htm MMWR September 23, 2014 / 63(Early Release);1-14 Population Liberia – 4.29M, Guinea 11.75M, Sierra Leone 6.09M 1 15 150 250 500 SENEGAL MALI GUINEABISSAU GUINEA SIERRA LEONE Guéckédou IVORY COAST LIBERIA 150 Miles Kenema NIGERIA Monrovia Areas affected as of Sept. 17 Comparison to Past Ebola Outbreaks 1976 (virus discovered) 2nd-worst year Sudan, Democratic Republic of Congo 602 cases (dark orange) 431 deaths (light orange) 1995 2000 2007 5th Democratic Republic of Congo 3rd Uganda 4th Uganda, Democratic Republic of Congo 425 cases 224 deaths 413 cases 224 deaths 315 cases 254 deaths 2014 1st Sierra Leone, Liberia, Guinea, Nigeria 4,963 cases 2,453 deaths as of Sept. 13 http://www.nytimes.com/interactive/2014/07/31/world/africa/ebola-virus-outbreak-qa.html?_r=0#history Previous Ebola Outbreaks WHEN WHERE # CASES MORTALITY 1976 Zaire 318 88% 1977 Sudan 34 65% 1994 Gabon 52 60% 1995 Congo 315 80% 1996 Gabon 37 57% 2000-01 Uganda 425 53% 2001-02 Gabon and Congo 122 79% 2002-03 Congo 143 89% 2003 Congo 35 83% 2004 S. Sudan 17 41% 2007 DRC 264 71% 2007-08 Uganda 149 25% 2008-09 DRC 32 47% 2012-13 DRC/Uganda 53 38% Why so Bad? It came to cities Burial rituals Culinary practices – Bushmeat, bats Patients hiding, distrustful, lack of knowledge Lack of adequate public sanitation Wide geographic spread, highly mobile population Lack of resources to isolate and do contact tracing THE VIRUS HAS NOT MUTATED TO BECOME AIRBORNE! 19 September 2014 Last updated at 04:58 ET Ebola outbreak: Guinea health team killed Some villagers in Guinea have been scared by the appearance of health workers trying to combat Ebola Some of the bodies - of health workers, local officials and journalists - were found in a septic tank in a village school near the city of Nzerekore. Correspondents say many villagers are suspicious of official attempts to combat the disease. http://www.bbc.com/news/world-africa-29256443 JFK Hospital in Monrovia Any positive signs? Numbers are WAY OFF and VASTLY UNDERESTIMATE the epidemic’s magnitude BUT… Number of new cases in some epicenters of outbreak have been dropping over weeks-months. Case incidence rate has declined in Guinea since 12/14 and in Liberia since 10/14 Improvement in safe burials MSF withdrawing from some areas Mali: outbreak over Ebola in HCW W. African HCW: 416 HCW, 233 deaths Medecins Sans Frontieres HCW: 700 HC workers deployed, 3 infected, 0 deaths We may continue to see cases in HCW We can protect ourselves Data from Stanford: 8 - 130 cases in US by end of 2014 Ebola in the US: 10 cases Emory: Kent Brantly, MD – HCW – ZMapp – recovered Nancy Writebol – HCW – Zmapp – recovered Ian Crozier, MD – HCW – recovered Amber Vinson – HCW in TX of ED – recovered NIH Nina Pham – HCW of ED – transfusion of Brantly - recovered NE Med Ctr Rick Sarca, MD – HCW – transfusion of Brantly and TKM – recovered Ashoka Mukpo – NBC cameraman – tx and brincidofovir – recovered Martin Salia, MD. Sierra Leonian, lives in US, symptoms in S.L – Zmapp and plasma – DIED 11/17 NY/Bellevue Craig Spencer, MD – HCW – brincidofovir - in hospital Texas Presbyterian Eric Duncan, Liberian tourist – brincidofovir - DIED Ebola in Travelers 86 of 1993 travelers to the US from Ebola-affected areas were referred for additional evaluation by the CDC. None diagnosed with EVD. Of 80,000 air passengers from EVD-affected countries between August and October, 2014, none who were denied travel because of screening have been reported as having Ebola, and of those allowed to travel, none are known to have had EVD symptoms during travel. Ebola in Africans Here No direct flights to or from Africa to DIA. DIA is a major connection hub for flights from Chicago O’Hare. Signs are posted Dallas Case The story 9/14 Eric Duncan cared for pregnant woman who died 9/19 He flew to Texas 9/24 Symptoms began 9/25 Dallas ER: T103, abd pain, nausea 9/28 Admitted ? Lag to isolation 9/30 Ebola confirmed 10/8 died 10/11 and 10/15 nurses positive What we learned There should be designated hospitals and designated caregivers In Denver: designated hospitals are Denver Health, University of Colorado, Children’s Ebola is only contagious when someone has symptoms and is ill R-naught Most Deadly Viruses 1. SMALLPOX: Killed 300 million in 20th century, wiped out in 1979 2. INFLUENZA: Killed 57 million since 1918, 250,000 deaths /year from seasonal flu 3. HIV: killed 39 million since 1981 4. ROTAVIRUS: 450,000 deaths / year 5. MEASLES: 122,000 deaths / year 6. YELLOW FEVER: 122,000 deaths / year 7. DENGUE: 22,000 deaths / year Ebola Virus Zoonotic virus – bats the most likely reservoir, although species unknown Spillover event from infected wild animals (e.g., fruit bats, monkey, duiker) to humans, followed by human-human transmission Reservoir Hemorrhagic fevers FILOVIRUSES ARENAVIRUSES Chapare HF (rural Bolivia), Lujo HF (S Africa), Lassa fever BUNYAVIRUSES Marburg and Ebola Crimean-Congo HF, HFRS, Hanta, Puumala, Rift Valley Fever… FLAVIVIRUSES Dengue, Yellow Fever, OMSK, Alkhurma All are RNA Viruses All are covered or enveloped All have a Natural Reservoir They are geographically distributed by the reservoir Death rates of 5 Ebola Species Transmission Highly infectious but not highly transmissible Index case likely becomes infected through contact with an infected animal Once an infection occurs in humans, the virus spreads through direct contact (through broken skin or mucous membranes) with A sick person's blood or body fluids (urine, saliva, feces, vomit, and semen) Objects (such as gloves, needles) that have been contaminated with infected body fluids (virus can survive in environment many days) Infected animals http://www.cdc.gov/vhf/ebola/transmission/index.html Sierra Leone NEJM, 2014:371:1481-95 Hemorrhagic signs 5.7% Symptoms Acute onset; typically 8–10 days after exposure (range 2–21 days) Signs and symptoms Initial: Fever, chills, myalgia, malaise, anorexia After 5 days: GI symptoms, such as nausea, vomiting, watery diarrhea, abdominal pain Other: Headache, conjunctivitis, hiccups, rash, chest pain, shortness of breath, confusion, seizures Hemorrhagic symptoms in 5-20% of cases Other possible infectious causes of symptoms Malaria, typhoid fever, meningococcemia, Lassa fever and other bacterial infections (e.g., pneumonia) – all very common in Africa Examples of Hemorrhagic Signs Hematemesis Gingival bleeding Bleeding at IV Site Diagnosis Laboratory findings may include low white blood cell and platelet counts and elevated liver enzymes. Virus detectable by real-time RT-PCR from 3-10 days after symptoms appear Collect a minimum volume of 4mL whole blood (preserved with EDTA) in plastic collection tubes All suspect cases should be immediately reported to the CDPHE Disease Control and Environmental Epidemiology Branch for approval for diagnostic testing Testing should encompass evaluation for other sources of febrile illness in the returned traveler Treatment Severely ill patients require intensive supportive care. Patients are frequently dehydrated and require oral rehydration with solutions containing electrolytes or intravenous fluids. No specific treatment is available. New drug therapies are being evaluated. Potential New Treatments Vaccines – several in development, GSK one starting trial Zmapp: 3 monoclonal synthetic antibodies that bind to protein of Ebola Brincidofovir: safety studies OK, works for other viruses, “shot in the dark” TKM Ebola: interferes with Ebola’s RNA Favipiravir: Used in Jaoan to treat Flu, shows promise against Ebola in animals Transfusions of plasma from recovered Ebola patient (Emory stockpiling) Amiodarone – ion channel blockers inhibit filoviral cell entry Inhaled Ebola Vaccine Inhaled Ebola vaccine may offer long-term protection from vinhaled Ebola vaccine may offer long-term protection from virus The University of Texas at Austin News, 11/07/2014 A potentially breathable, respiratory vaccine in development has been shown to provide long–term protection for non–human primates against the deadly Ebola virus, as reported this week in the online edition of the journal Molecular Pharmaceutics. Results from a recent pre–clinical study represent the only proof to date that a single dose of a non–injectable vaccine platform for Ebola is long lasting, which could have significant global implications in controlling future outbreaks. A breathable vaccine could surmount the logistical obstacles of storing, transporting and administering injectable vaccines in parts of Africa most afflicted by the virus. Professor Maria Croyle and graduate student Kristina Jonsson–Schmunk of The University of Texas at Austin’s College of Pharmacy, who co–authored the paper with Dr. Gary Kobinger and his team at the National Microbiology Laboratory in Winnipeg, will make a presentation on the newly published work at the 2014 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition.rus The University of Texas at Austin News, 11/07/2014 Ask! dAsky AboutdEbola ASKd yyAboutytravelyyy dddToddSi erradLeone,dGui nea,dLi beri adji n dWestdAfri ca&d dddindthedpastd21ddays. ddAnddexposure dddTodpersonsdwi thdEbola. ddAnddsymptomsd dddFever,dheadache,djoi ntdFdmuscledaches,dweak ness,dddd dddfati gue,ddi arrhea,dvomi ti ng,dstomachdpai n,dlossdofdd dddappeti te,dsometi mesdbleedi n g. ISOLATEyy yyyIfytravelyoryexposureycriteriayareymetyandytheypersonyhasyy yyysymptomsyofyEbola2yplaceytheypersonyinyayprivateyroom( CALLyUS yyyNotifyyhospitalyleadershipyandyCDPHEyaty3) 3(692(27) ) y yyy3afteryhoursy3) 3(37) (93950( w w w (colorado(go v5ebola CDPHE Flyer Algorithm CDPHE: ASK, ISOLATE, CALL ASK everyone, everytime ISOLATE if travel or exposure history AND symptoms About travel to Sierra Leone, Guinea or Liberia within 21 days. About exposure to anyone with Ebola About signs and symptoms Private room, private bath, limit personnel and determine PPE Call: Notify Infection Control and Task Force. Call CDPHE 303-692-2700 (afterhours: 303-370-9395) CDC Guidance for Infection Control Component Patient Placement Personal Protective Equipment (PPE) (special attention to donning and doffing sequence) Patient Care Equipment Recommendation •Single patient room (containing a private bathroom) with the door closed •Facilities should maintain a log of all persons entering the patient's room •All persons entering the patient room should wear at least: •Gloves •Gown (fluid resistant or impermeable) •Eye protection (goggles or face shield) •Facemask •Additional PPE might be required in certain situations (e.g., copious amounts of blood, other body fluids, vomit, or feces present in the environment), including but not limited to: •Double gloving •Disposable shoe covers •Leg coverings •N95 respirator or higher (PAPR) for aerosol generating proc. •Dedicated medical equipment (preferably disposable, when possible) •Non-dedicated, non-disposable equipment used for patient care should be cleaned and disinfected according to manufacturer's instructions http://www.medscape.com/viewarticle/8 33907 Donning and Doffing of PPE video Keys to PPE Always work in pairs, have an observer Those using PPE must be comfortable with the PPE Doffing to avoid contamination Be tedious – takes 15 minutes Don’t touch face Perform hand hygiene between each step CDC Ebola Guidance Ambulatory Care Evaluation of Patients with Possible Ebola Virus Disease (Ebola)[PDF 1 page] Infection Prevention and Control for Hospitalized Patients with Known or Suspected Ebola in U.S. Hospitals Guidance on Personal Protective Equipment To Be Used by Healthcare Workers During Management of Patients with Ebola Virus Disease in U.S. Hospitals, Including Procedures for Putting On (Donning) and Removing (Doffing) Environmental Infection Control in Hospitals for Ebola Virus – Interim Guidance Ebola-Associated Waste Management Recommendations for Safely Performing Acute Hemodialysis in Patients with Ebola Virus Disease in U.S. Hospitals Safe Handling of Human Remains of Ebola Patients in U. S. Hospitals and Mortuaries Ebola or Flu Websites www.colorado.gov/ebola COHELP (for patients) 303-389-1687 or 1-877-462-2911 www.cdc.gov/ebola Checklist for Patients Being Evaluated for Ebola Virus Disease (EVD) in the United States Ebola Virus Disease (Ebola) Algorithm for Evaluation of the Returned Traveler